Author: foodpoisoningnews

[ad_1] For Immediate Release March 20, 2019 Contact Consumers Kingston Pharma, LLC  [email protected].  1-844-724-7347 Announcement View Product Photos Kingston Pharma, LLC of Massena, NY is recalling Lot KL180157 of its 2-fluid ounce (59 mL) bottles of DG™/health NATURALS baby Cough Syrup + Mucus” because it has the potential to be contaminated with Bacillus cereus/ Bacillus circulans. Bacillus cereus in food products has the potential to produce two forms of gastrointestinal illness, one being a syndrome primarily of vomiting, and the other of diarrhea.  Most often, illnesses are mild and self-limiting, although more serious and even lethal cases have occurred.  Individuals…

Read More

[ad_1] Kingston Pharma, LLC of Massena, NY is recalling Lot KL180157 of its 2-fluid oz (59 mL) bottles of DG™/wellness NATURALS infant Cough Syrup + Mucus” since it has the potential to be contaminated with Bacillus cereus/ Bacillus circulans. Bacillus cereus in food products has the capacity to produce two kinds of gastrointestinal disorder, one being a syndrome chiefly of nausea, and another of diarrhea. Most frequently, illnesses are mild and self-limiting, even more severe and even deadly cases have happened. People at risk for more severe forms of illness include infants, young children, and others with weakened immune systems.…

Read More

[ad_1] Kingston Pharma, LLC of Massena, NY is recalling Lot KL180157 of its 2-fluid oz (59 mL) bottles of DG(TM)/wellbeing NATURALS infant Cough Syrup + Mucus” since it has the potential to be contaminated with Bacillus cereus/ Bacillus circulans. Bacillus cereus in food products has the capacity to produce two kinds of gastrointestinal disorder, one being a syndrome chiefly of nausea, and another of diarrhea. Most frequently, illnesses are mild and self-limiting, even more serious and even deadly cases have happened. People at risk for more serious forms of illness include infants, young children, and others with weakened immune systems.…

Read More

[ad_1] Hospira, Inc., a Pfizer company, is voluntarily recalling lot numbers 79-238-EV, 79-240-EV and 80-088-EV, NDCNumber 0409-6625-02, of 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL), to the Hospital/Institution level. The recall was initiated because of the presence of particulate matter, confirmed as glass. [ad_2] Source link

Read More